Research Paper Volume 16, Issue 9 pp 7647—7667
GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction
Figure 8. GJB3 expression in non-tumor and tumor tissues based on immunohistochemistry. (A, B) The expression of GJB3 in LUAD (A) and SKCM (B) was higher in cancer tissues than in non-cancer tissues.